Market closed

Clene/CLNN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Clene

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

Ticker

CLNN
Trading on

Industry

Biotechnology

Employees

84
Website

Clene Metrics

BasicAdvanced
$39M
Market cap
-
P/E ratio
-$4.74
EPS
0.46
Beta
-
Dividend rate
$39M
0.46
$13.20
$3.82
82K
0.994
0.816
-2,290.278
-6,472.024
-7.35%
-41.71%
-289.66%
72.023
-63.19
-63.19
-1.159
-43.62%
-64.10%
-6.52%
-43.88%

What the Analysts think about Clene

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Clene stock.

Clene Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Clene Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy CLNN

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Clene stock?

Clene (CLNN) has a market cap of $39M as of October 05, 2024.

What is the P/E ratio for Clene stock?

The price to earnings (P/E) ratio for Clene (CLNN) stock is 0 as of October 05, 2024.

Does Clene stock pay dividends?

No, Clene (CLNN) stock does not pay dividends to its shareholders as of October 05, 2024.

When is the next Clene dividend payment date?

Clene (CLNN) stock does not pay dividends to its shareholders.

What is the beta indicator for Clene?

Clene (CLNN) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.